Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Nick Devoogdt actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
HERC58: SPECY-SORT: SPEctrale flowCYtometer en celSORTer
Laoui, D., De Veirman, K., Van der Henst, C., Brunner, J., Messens, J., Raes, G., Van Ginderachter, J., Devoogdt, N., Magez, S., Remaut, H. K., Stijlemans, B., Movahedi, K., Peeters, E. & De Trez, C.
1/05/22 → 30/04/26
Project: Fundamenteel
-
HERC59: PET camera voor beeldvorming van kleine proefdieren
Devoogdt, N., Raes, G., Lahoutte, T., Van Ginderachter, J., Caveliers, V., Keyaerts, M., Hernot, S. & D'Huyvetter, M.
1/05/22 → 30/04/26
Project: Fundamenteel
-
HERC56: Intravitale beeldvorming als technologie om de kloof te dichten tussen macroscopische in vivo beeldvorming en microscopische analyse van weefsels
Hernot, S., Staels, W., Hellemans, K., Smolders, I., Rooman, I., Devoogdt, N., Menu, E., De Bundel, D., Breckpot, K., De Leu, N., Movahedi, K., D'Huyvetter, M. & De Kock, J.
1/05/22 → 30/04/26
Project: Fundamenteel
-
OZR3941: Cofinanciering OZR FWO Hercules MZW: SPECY-SORT: SPEctrale flowCYtometer en celSORTer
Laoui, D., Van Ginderachter, J., Movahedi, K., De Veirman, K., Magez, S., De Trez, C., Stijlemans, B., Raes, G., Devoogdt, N., Messens, J., Brunner, J., Remaut, H. K., Fioravanti, A., Peeters, E. & Van der Henst, C.
16/03/22 → 16/03/25
Project: Fundamenteel
-
FWOAL1045: Gepersonaliseerde therapie gericht tegen het AXL eiwit voor de behandeling van acute myeloide leukemie en multipel myeloom
De Veirman, K., Devoogdt, N. & Vanderkerken, K.
1/01/22 → 31/12/25
Project: Fundamenteel
Onderzoeksoutput
-
Emerging applications of nanobodies in cancer therapy
Awad, R. M., Meeus, F., Ceuppens, H., Ertveldt, T., Hanssens, H., Lecocq, Q., Mateusiak, L., Zeven, K., Valenta, H., De Groof, T. W. M., De Vlaeminck, Y., Krasniqi, A., De Veirman, K., Goyvaerts, C., D'Huyvetter, M., Hernot, S., Devoogdt, N. & Breckpot, K., 2022, In : International review of cell and molecular biology. 369, blz. 143-199 57 blz.Onderzoeksoutput: Article
-
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy
Barca, C., Griessinger, C. M., Faust, A., Depke, D., Essler, M., Windhorst, A. D., Devoogdt, N., Brindle, K. M., Schäfers, M., Zinnhardt, B. & Jacobs, A. H., jan 2022, In : Pharmaceuticals. 15, 1, 20 blz., 13.Onderzoeksoutput: Article
Open Access3 Citaten (Scopus) -
Preclinical validation of [18F]-FB-(Anti Human PD-L1) Nanobody for PET imaging
Dierick, H., Breckpot, K., Devoogdt, N., Keyaerts, M., Caveliers, V., Lahoutte, T. & Bridoux, J., 22 mei 2022.Onderzoeksoutput: Poster
Open Access -
Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
Ertveldt, T., De Beck, L., De Ridder, K., Locy, H., De Mey, W., Goyvaerts, C., Lecocq, Q., Ceuppens, H., De Vlaeminck, Y., Awad, R. M., Keyaerts, M., Devoogdt, N., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 2022, In : Molecular Cancer Therapeutics.Onderzoeksoutput: Article
Open Access -
The road to personalized myeloma medicine: Patient-specific single-domain antibodies for anti-idiotypic radionuclide therapy
Puttemans, J., Stijlemans, B., Keyaerts, M., Vander Meeren, S., Renmans, W., Fostier, K., Debie, P., Hanssens, H., Rodak, M., Pruszynski, M., De Veirman, K., Vanderkerken, K., Lahoutte, T., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., jan 2022, In : Molecular Cancer Therapeutics. 21, 1, blz. 159-169 11 blz.Onderzoeksoutput: Article
Open AccessBestand4 Citaten (Scopus)60 Downloads (Pure)
Prijzen
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Ahmet Krasniqi (Recipient), Matthias D'Huyvetter (Recipient), Nick Devoogdt (Recipient) & Marleen Keyaerts (Recipient), 16 apr 2019
Prijs: Prize (including medals and awards)
-
Certificat of Young Speaker Award
Quentin Lecocq (Recipient), Katrijn Broos (Recipient), Jessica Bridoux (Recipient), Geert Raes (Recipient), Catarina Xavier (Recipient), Nick Devoogdt (Recipient), Marleen Keyaerts (Recipient) & Karine Breckpot (Recipient), 1 feb 2019
Prijs: Prize (including medals and awards)
Bestand -
ESMI presentation award for best oral presentation
Jessica Bridoux (Recipient), Katrijn Broos (Recipient), Quentin Lecocq (Recipient), Maxine Crauwels (Recipient), Charlotte Martin (Recipient), Frederik Cleeren (Recipient), Mikhail Kondrashov (Recipient), Steven Ballet (Recipient), G. Bormans (Recipient), Magnus Schou (Recipient), Chad Elmore (Recipient), Geert Raes (Recipient), Karine Breckpot (Recipient), Serge Muyldermans (Recipient), Nick Devoogdt (Recipient), Marleen Keyaerts (Recipient), Vicky Caveliers (Recipient) & Catarina Xavier (Recipient), 17 jan 2020
Prijs: Prize (including medals and awards)
-
Knowledge for Growth 2018 Ghent - poster award
Katrijn Broos (Recipient), Quentin Lecocq (Recipient), Jessica Bridoux (Recipient), Geert Raes (Recipient), Catarina Xavier (Recipient), Marleen Keyaerts (Recipient), Nick Devoogdt (Recipient) & Karine Breckpot (Recipient), 18 mei 2018
Prijs: Prize (including medals and awards)
-
Non-invasive imaging of atherosclerosis with Nanobodies
Jens De Vos (Recipient) & Nick Devoogdt (Recipient), 25 nov 2010
Prijs: Other distinction
Activiteiten
-
Using the site-specific radiolabeling of a PD-L1 nanobody via maleimide–cysteine chemistry to develop a PET-tracer as screening tool for personalized oncology treatment
Dora Mugoli Chigoho (Speaker), Jessica Bridoux (Speaker), Catarina Xavier (Speaker), Vicky Caveliers (Speaker), Marleen Keyaerts (Speaker), Nick Devoogdt (Speaker), Karine Breckpot (Speaker), Robin Maximilian Awad (Speaker), Quentin Lecocq (Speaker)7 mei 2022Activiteit: Talk or presentation at a conference
-
Preclinical validation of [18F]-FB-(Anti Human PD-L1) Nanobody for PET imaging
Herlinde Dierick (Speaker), Karine Breckpot (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor), Vicky Caveliers (Contributor), Tony Lahoutte (Contributor), Jessica Bridoux (Contributor)7 mei 2022Activiteit: Talk or presentation at a conference
-
Granted Project Scientific Fund Willy Gepts: Development of a nanoCAR-T cell approach for the treatment of multiple myeloma
Heleen Hanssens (Supervisor), Nick Devoogdt (Supervisor), Karine Breckpot (Supervisor)1 jan 2022 → 1 jan 2026Activiteit: Other
-
Human relevant models for drug research and development
Fien Meeus (Speaker), Robin Maximilian Awad (Contributor), Nick Devoogdt (Contributor), Sandra Tuyaerts (Contributor), Cleo Goyvaerts (Contributor), Yannick De Vlaeminck (Contributor), Bart Neyns (Contributor), Karine Breckpot (Contributor)8 okt 2021Activiteit: Talk or presentation at a workshop/seminar
-
2021-80
Nick Devoogdt (Supervisor), Timo De Groof (Contributor), Fien Meeus (Contributor), Karine Breckpot (Contributor), Yannick De Vlaeminck (Contributor)2021 → …Activiteit: Other
Knipsels
-
Betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
8/02/22
1 item van Media-aandacht
Pers / media: !!Research
-
VUB-onderzoekers en start-up Esobiotec willen kankerimmunotherapie betaalbaarder maken
Karine Breckpot, Nick Devoogdt, Fien Meeus & Yannick De Vlaeminck
31/01/22
1 item van Media-aandacht
Pers / media: !!Research
-
VUB-onderzoekers en start-up Esobiotec streven naar betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
31/01/22
1 Mediabijdrage
Pers / media: !!Research
-
EsoBiotec ready to transform cell therapy cancer treatments
Karine Breckpot & Nick Devoogdt
30/09/21
1 item van Media-aandacht
Pers / media: !!Research
-
Mini-antibodies discovered in sharks and camels could lead to drugs for cancer and other diseases
10/05/18
1 Mediabijdrage
Pers / media: !!Research
Scriptie
-
Analysis of the metastasis-promoting effect of human secretory leukocyte protease inhibitor.
Auteur: Jing, Z., De Baetselier, P. & Devoogdt, N., 2001Begeleider: De Baetselier, P. (Promotor) & Devoogdt, N. (Co-promotor)
Scriptie/masterproef: Master's Thesis
-
A novel generation of affitins for targeting cancer cells with drug-loaded lipid nanocapsules
Auteur: Kalichuk, V., Pecorari, F., Préat, V. & Devoogdt, N., 16 okt 2017Scriptie/masterproef: Doctoral Thesis
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Auteur: Meeus, F., Hanssens, H., De Veirman, K. & Devoogdt, N., 19 jun 2020Begeleider: Hanssens, H. (Advisor)
Scriptie/masterproef: Master's Thesis
-
Assessment of properties affecting the differential biodistribution and pharmacokinetic clearance of nanobodies via the kidneys by generating chimeras.
Auteur: Tchafack Kaze, J. M., Muyldermans, S., Devoogdt, N. & Vincke, C., jan 2013Begeleider: Muyldermans, S. (Promotor), Devoogdt, N. (Co-promotor) & Vincke, C. (Advisor)
Scriptie/masterproef: Master's Thesis
-
Bead based immunoassay of HER2 ECD domain using nanobodies
Auteur: Adaga, E., Muyldermans, S., De Pauw, P. & Devoogdt, N., 1 sep 2015Scriptie/masterproef: Master's Thesis